PTOISBIC-SOEFS (02—18)
`Doc code: RCEX
`Approved for use through 11130-0020- OMB 0651 -0031
`Doc description: Request for Continued Examination (RCE)
`us. Patent and Trademark Office; us. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`
`REQUEST FOR CONTINUED EXAMINATION(RCE)TRANSMITI'AL
`(Submitted Only via EFS-Web)
`
`51582194
`
`Fi'ing
`Date
`
`017—05—01
`
`p°°ket.Number
`Applicatb”
`(If applicable)
`Number
`First Named ARATA KISHI
`Examiner
`Pevang R. Patel
`
`Name
`Inventor
`This is a Request for Continued Examination (RCE) under 37 CFR 1.114 of the above-identified application.
`Request for Continued Examination (RCE) practice under 37 CFR 1.114 does not apply to any utility or plant application filed prior to June 8,
`1995, or to any design application. The Instruction Sheet for this form is located at WWW.USPTO.GOV
`
`'lPMM—57489
`
`
`
`
`SUBMISSION REQUIRED UNDER 37 CFR 1.114
`
`
`Note: If the RCE is proper, any previously filed unentered amendments and amendments enclosed with the RCE will be entered in the order
`in which they were filed unless applicant instructs otherwise. If applicant does not wish to have any previously filed unentered amendment(s)
`entered, applicant must request non—entry of such amendment(s).
`
`|:| Previously submitted. If a final Office action is outstanding, any amendments filed after the final Office action may be considered as a
`submission even if this box is not checked.
`
`|:| Consider the arguments in the Appeal Brief or Reply Brief previously filed on
`
`|:| Other
`
`|X| Enclosed
`
`|Z| Amendmentheply
`
`|:|
`
`Information Disclosure Statement (IDS)
`
`|:| Affidavit(s)l Declaration(s)
`
`|:| Other
`
`MISCELLANEOUS
`
`El Suspension of action on the above-identified application is requested under 37 CFR 1.103(c) for a period of months
`(Period of suspension shall not exceed 3 months; Fee under 37 CFR 1.17(i) required)
`
`|:| Other
`
`The RCE fee under 37 CFR 1.17(e) is required by 37 CFR 1.114 when the RCE is filed.
`|Z| The Director is hereby authorized to charge any underpayment of fees, or credit any overpayments, to
`Deposit Account No
`160820
`
`
`SIGNATURE OF APPLICANT, ATTORNEY, OR AGENT REQUIRED
`
`FEES
`
`X Patent Practitioner Sig nature
`
`Applicant Signature
`
`EFS - Web 2.1.16
`
`

`

`Doc code: RCEX
`PTOISBiC-SOEFS (02—18)
`Approved for use through 1113012020. OMB 0651 —0031
`Doc description: Request for Continued Examination (RCE)
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
` Signature of Registered U.S. Patent Practitioner
`
`
`
`
`
`This collection of information is required by 37 CFR 1.114. The information is required to obtain or retain a benefit by the public which is to
`file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S_C. 122 and 37 CFR 1.11 and 1.14. This collection is
`estimated to take 12 minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time
`will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/0r suggestions for
`reducing this burden, should be sent to the Chief Information Officer, US. Patent and Trademark Office, US. Department of Commerce,
`PO. Box 1450, Alexandria, VA 22313—1450.
`if you need assistance in completing the form, salt 1 —800—PTO—9 199 and select option 2.
`
`EFS - Web 2.1.16
`
`